















































Although the klotho gene was first reported to retard 
aging in mice [1, 2], human Klotho gene poly-
morphisms have been significantly linked with reduced 
longevity [3]. The human Klotho gene encodes either a 
type II transmembrane protein, consisting of two 
extracellular  β-glucosidase-like domains (KL1 and 
KL2),  or a putative secreted form, resulting  from  alter- 
 
 













































native splicing that leads to the production of a single 
KL1 domain [4]. In addition, both full KL1-KL2 
extracellular domain (130 kDa) and/or C-terminal KL1 
(68 kDa) domain have been reported to be released 
from the membrane-bound isoform by proteolytic 
cleavage that involves ADAM10 and ADAM17 
proteases [5]. While the membrane-bound Klotho 
isoform is mainly expressed in distal convoluted tubules 
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as a 130 kDa polypeptide in the cerebrospinal fluid, 
blood, and urine [6, 2]. Therefore, this 130 kDa Klotho 
polypeptide has been referred as the secreted form of 
Klotho [7]. 
 
In human cells, the alternative transcript, encoding for 
the KL1 domain, predominates over the full length 
transcript encoding for the membrane-bound isoform of 
Klotho [4]. The KL1 secreted isoform has not yet been 
documented, possibly on account of a lack of KL1 
secreted isoform detection in body fluids. 
 
After a decade of extensive studies in mammals, 
different Klotho isoforms appear to play distinct 
functions. The membrane-bound isoform acts as an 
obligate co-receptor for FGF23 [8, 9] by interacting 
with Fibroblast Growth Factor Receptors (FGFRs) in 
the kidney. FGF23 is a bone-derived hormone that 
inhibits both phosphate reabsorption as well as vitamin 
D biosynthesis. Interestingly, mice lacking either 
Klotho or FGF23 exhibit a premature-aging syndrome 
[10], which reveals an unexpected link between 
phosphate metabolism and aging (reviewed in [7]). The 
secreted Klotho acts as an endocrine regulator of several 
cell surface glycoproteins, including ion channels or 
growth factor receptors, such as the insulin/Igf-like 
receptors. Moreover, the latter have been involved in 
aging control and stress resistance (reviewed in [11, 
12]). Whereas the putative sialidase activity of the 
secreted Klotho may inhibit the internalization of 
calcium TRPV5 [13] and potassium ROMK1 [14] 
channels, the mechanism by which the secreted Klotho 
isoform inhibits Ins/Igf-like receptor activity remains to 
be determined. Thus, the effects of both Klotho 
isoforms converge towards a positive modulation of 
lifespan, but the underlying molecular mechanisms are 
far from being understood.  
 
A  C. elegans lifespan extension can be achieved by 
reduced Daf-2/insulin/Igf-like signalling  [15, 16]. 
Furthermore, lifespan modulation effects have been also 
reported in worm [17, 18, 19], fly [20, 21] and mice [22, 
23] upon downregulation of the conserved insulin/Igf-
like pathway. 
 
A single FGFR (EGL-15) and two FGF ligands (LET-
756 and EGL-17) have been identified in C. elegans. 
While LET-756 plays an essential function in regulating 
fluid balance [24], EGL-17 is involved in sex myoblast 
(SM) migration [25].  Thus, two ligands can mediate 
specific functions depending on tissue-specific receptor 
isoform expression. EGL-15(5A) is predominantly 
expressed in the worm M cell lineage and is necessary 
for the gonadal chemoattraction of the migrating SM 
[25] while EGL-15(5B), which is principally localized 
in the hypodermis, is required for viability [26, 27]. 
However, despite specific phenotypes that have been 
already reported, some redundant functions have been 
reported for both LET-756 and EGL-17. For instance, 
EGL-15 activation by either LET-756 or EGL-17 is 
involved in protein degradation in C. elegans muscle 
[28].  
 
Here, we report that two Klotho gene homologues exist 
in the nematode. In addition, we present genetic 
evidence for EGL-15 (FGFR) requirement by Klotho to 
regulate longevity and oxidative stress resistance in C. 
elegans.  
 
In addition, we also examined FGFs ligands in C. 
elegans and found that between the two known EGL-15 
ligands, only EGL-17 (that is homologous to the 
mammalian FGF8 subfamily) appears necessary and 
sufficient to induce Klotho signalling. Besides the 
report of a new post-developmental and specific role for 
EGl-17 in the regulation of both aging and oxidative 
stress resistance, our results reveal an unexpected link 
between Klotho and a novel, FGF23-independent, FGF-
signalling pathway. We also report a genetic interaction 
between Klotho and the Daf-2/insulin/Igf-like signalling 
pathway.  
 
While lifespan regulation requires a functional Daf-
2/insulin/Igf-like signalling cascade, the control of 
oxidative stress resistance involves both a DAF-2- 
independent and a DAF-16-dependent pathway, 
suggesting that Klotho may target either DAF-2 or 
DAF-16, depending on environmental cues. Taken 
together, our findings strongly indicate that a predicted 
KL1 isoform of Klotho requires the FGF signalling 
pathway to crosstalk with the Daf-2/insulin/Igf-like 
pathway, in order to regulate aging and oxidative stress 




1- Genetic characterization of the two klotho genes in 
C. elegans 
 
The  C. elegans genome contains two sequences 
homologous to the mammals klotho gene  : C50F7.10   
and  E02H9.5. Although these two paralogues differ in 
their genomic organization (Figure 1A), they encode 
ORFs of similar size and appear genetically redundant, 
since no obvious function emerged from previous mass 
RNA-mediated gene interference (RNAi) assays [29]. 
In addition, a sole putative klotho gene has been 
predicted in the C. briggsae genome [30]. Considering 
that the latter species diverged from C. elegans ~100 
millions years ago, it is probable that a unique gene has 
been retained by evolution.  
   



























































































































www.impactaging.com                    569                                    AGING,    September 2010, Vol.2 No.9The predictive sequences of the C50F7.10 and E02H9.5 
gene products (479 and 475 amino-acids, respectively) 
are 76% identical and share 32 to 34% amino acid 
identity with their mammalian counterparts. Interestingly, 
both C. elegans predicted gene products consist of a sole 
β-glucosidase-like domain that is homologous to the 
highly conserved KL1 domain of human and mouse 
Klotho proteins but that lacks a secretory signal peptide 
















































nism, via an endoplasmic reticulum/Golgi complex-
independent pathway, cannot be excluded. Such a 
mechanism has been described in mammals for some 
secreted FGFs [31, 32]. Furthermore, the membrane-
bound Klotho could not be observed at the surface of 
kidney cells in mammals, but only as a diffuse expression 
in the cytoplasm. In addition, a combination of both 
conventional and a novel, Klotho-dependent, secretory 
pathways has also been reported [33, 34]. 
 
2- Klotho requires the EGL-17/EGL-15 (FGF-R) 
complex to regulate C. elegans longevity 
 
To analyse the in vivo function of Klotho in C. elegans, 
we have chosen a genetic approach by using RNA-
mediated gene interference (RNAi). To circumvent the 
genetic redundancy of C50F7.10 and E02H9.5, we 
designed RNAi capable of simultaneously reducing the 
expression of both paralogues.  
 
As previously reported in mammals [1], we then 
assessed whether klotho gene knockdown can affect 
worm lifespan. As expected, N2 (wild type) worms 
showed a highly significant reduction (LogRank p < 
0.0001) of longevity when submitted to klotho RNAi, in 
comparison with control (Figure 2A; Table 1). Similar 
results were observed when the E02H9.5 (ok1830) 
knockout strain was tested in place of the N2 (wild 
type) strain, supporting the genetic redundancy of the 
two paralogues (not shown).  
 
In mammalian cells, the membrane-bound Klotho 
isoform has been reported to bind to multiple FGFRs, 
increasing their affinity to FGF23. Because of its weak 
affinity to FGF23, the secreted Klotho is not likely to 
function as a soluble co-receptor for FGF23. Whether 
this secreted Klotho product can modulate lifespan by 
interacting with FGF signalling in a FGF23 independent 




















modulate  lifespan.  Adult  worm  lifespan  analysis  was
performed  at  20°C  on  RNAi  plates  as  described  in  the  text.
Animals of indicated genotype were submitted to either klotho
RNAi (solid symbol) or control L4440 vector RNAi (open symbol)
throughout  adulthood.  See  Table  1  for  corresponding
quantitative data and statistical analysis.  
   













































We then asked whether FGF signalling is a determinant 
in the regulation of worm lifespan by Klotho.  To avoid 
possible redundant effects of the two EGL-15 ligands, 
we first tested whether klotho gene deficiency alters 
lifespan in an egl-15 gene-dependent manner.  
 
As shown in Figure 2B and Table 1, the mean life-span 
of the egl-15  (n484) reduction-of-function allele, fed 
with either control or klotho RNAi, was clearly identical 
to N2 (wild-type) worms fed with klotho RNAi only 














































Downregulation of both egl-15 and klotho genes 
reduces lifespan by a similar order of magnitude, 
strongly suggesting that the entire modulation of 
lifespan by klotho gene in worms, is mediated by the 
FGFR EGL-15. Interestingly, egl-15  (n484) has been 
reported to mimic the phenotype of an egl-17 reduction-
of-function allele [35]. On the basis of this mutant allele 
effect, we then assessed whether klotho gene deficiency 
might alter lifespan in an egl-17 gene-dependent 
mechanism. As expected (Figure 2C; Table 1), the mean 
lifespan of the egl-17 (n1377) reduction-of-function 
The  tabulated  data  show  the  average  results  of  four  to  eight  independent  RNAi  trials  at  20°C.  Worms  of  indicated
genotypes were assayed for life span by feeding on E. coli HT115 strain bacteria producing either control or klotho RNAi
(see Material and Methods). XLSTAT‐life statistical software (Addinsoft, New York, NY, USA) was used to plot survival data
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comparable to that of N2 (wild-type) worms fed with 
Klotho RNAi only (LogRank p = 0.235; p = 0.261, 
respectively). Since either reduction-of-function of egl-
17 or klotho gene knock down can impair worm 
lifespan to a similar degree, our data indicate that EGL-
17 alone (of the EGL-15 ligands) is necessary and 
sufficient to modulate lifespan in a Klotho-dependent 
manner. Moreover, we demonstrate, for the first time, a 
specific involvement of EGL-17 for normal post-
developmental events in worm. Taken together, our 
results support genetic evidence that Klotho can signal 
via the EGL-17/EGL-15 pathway to regulate worm 
lifespan in physiological conditions.  
 
Of the two known FGFR ligands in worm, LET-756 has 
been primarily implicated in fluid balance regulation 
[24], and more recently in muscle protein degradation 
[28]. However, because of the essential function 
accomplished by LET-756, we were not able to assess 
its implication in the regulation of lifespan, but we 
cannot exclude that it does not also play a role. 
Moreover, according to our results, such a potential role 
should be independent of Klotho.  
 
3- Klotho is not involved in the worm fluid balance 
homeostasis 
 
In  C. elegans, the vital maintenance of fluid 
homeostasis is under the control of the LET-756/EGL-
15 (B) complex which activates the LET-60 (RAS) 
/MPK-1 (MAPK) pathway [36]. Such a regulatory 
pathway is reminiscent of the role of FGF23 in the 
kidney, where it regulates ionic homeostasis and, 
therefore, helps in the maintenance of global fluid 
balance. In fact, the mammalian FGF-
23/Klotho  /FGFR-1 complex has been reported to 
activate the MAP kinase pathway [8]. 
 
We then assessed for a possible link between Klotho 
and functions implicating LET-756/EGL-15. In C. 
elegans, the existence of a negative regulator of FGFR 
signalling allows genetic activation of EGL-15.  EGL-
15 (FGFR) signalling is normally attenuated by a 
receptor tyrosine phosphatase, encoded by the clr-1 
gene. Reduced CLR-1 receptor activity provokes an 
over-activation of EGL-15 (FGFR) signalling leading to 
a Clr (clear) phenotype, characterized by fluid 
accumulation within the pseudo-coelom [37]. Thus, clr-
1 mutants have proven useful for screening Soc 
(suppressor of Clr) regulators, which can reverse the Clr 
phenotype by decreasing EGL-15 signalling [35, 36]. 
 
We took advantage of the Clr model phenotype 
described above to assess whether klotho gene 
deficiency might diminish EGL-15 signalling in a clr-1 
genetic background and thus suppress, at least partially, 
the Clr phenotype. 
 
When temperature-sensitive allele clr-1(e1745) worms 
are shifted to restrictive temperature (25°C), they 
develop a Clr phenotype. We then pre-induced clr-
1(e1745) worms to either klotho or control RNAi at 
permissive temperature (15°C) before shifting them  to 

















































Adult  worms  were  pre‐induced  with  either  klotho  or  control
RNAi  at  permissive  temperature  (15°C),  prior  to  being  either
maintained at 15°C or shifted to restrictive temperature (25°C)
which  allows  the  development  of  a  Clr  phenotype.  (A)
Experiments  were  conducted  in  a  clr‐1(e1745)  genetic
background. The induced Clr phenotype is characterized by both
intestine  and  gonad  floating  in  an  enlarged  fluid‐filled
pseudocoelomic  cavity.  (B)  Controls,  performed  in  a  clr‐
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suppress the Clr phenotype, characterized by both 
intestine and gonad floating in an enlarged fluid-filled 
pseudocoelomic cavity. As controls, similar experiments 
were done using a clr-1(e1745); let-756(s2613) 
reduction-of-function double mutant in place of clr-
1(e1745)  mutant allele. In accordance with Borland’s 
data [36], our results show that let-756 gene activity 
reduction leads to a partial suppression of the Clr 
phenotype (Figure 3B). However, this latter observation 
appears to be independent of the klotho gene status. 
 
Taken together, our data suggest that Klotho is not 
involved in the maintenance of fluid balance in the 
nematode.  Furthermore, our observations again argue 
for a lack of interaction between Klotho and the LET-
756 ligand. 
 
4- Klotho targets the C. elegans Insulin/Igf-like/Daf-
2 receptor and requires Daf-2/Daf-16 signalling 
pathway for lifespan modulation  
 
Overexpression of Klotho in mice has been reported to 
inhibit the activation of the Insulin/Igf-like receptor [2]. 
Furthermore, loss-of-function of the worm daf-2 gene, 






























worm lifespan [38]. We therefore asked whether Klotho 
behaves in the same way, by acting as a constitutive 
Insulin/Igf-like signalling pathway repressor, in worm. 
With this in mind, we assessed whether klotho gene 
deficiency can modulate worm lifespan in a daf-2 gene-
dependent manner. Statistical analysis (Table 2) showed 
that  klotho knockdown failed to induce detectable 
lifespan modulation (LogRank p = 0.027) in a daf-2 
(e1370) genetic background (Figure 4B). However, we 
detected (Table 2) a slightly significant lifespan 
modulation (LogRank p = 0.002) when klotho 
knockdown was assessed in a daf-2 (m577) genetic 
background (Figure4C). One possible explanation for 
such a Klotho RNAi effect discrepancy between the two 
daf-2 reduction-of-function alleles assessed for lifespan 
could be differences in their daf-2 mutant class. Thus, 
while daf-2 (e1370) belongs to the daf-2 class 2-allele 
and behaves as a kinase-dead-like mutant, the daf-2 
(m577) reduction-of-function allele, which belongs to 
the daf-2 class 1-allele, is modified by a point-mutation 
in the ligand-binding site and therefore may exhibit 
residual, ligand-independent, catalytic activity [39, 40]. 
Taken together, our data argue for in vivo lifespan 
modulation by Klotho mediated by the Insulin/Igf-
like/Daf-2 receptor activity by either a ligand-dependent 
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diminish the recruitment of phosphatidyl-inositol 3-
kinase (PI3-kinase) regulatory subunits that normally 
leads to Insulin/Igf-like receptor activation [2]. How-
ever, to date, the direct inhibition of PI3-kinase catalytic 
activity by Klotho has not been demonstrated. We 


















































worms by submitting the strong loss-of-function allele 
age-1(mg44) mutant to klotho knockdown. As shown 
(Figure 4D; Table 2) we cannot detect any significant 
(LogRank p = 0.077) lifespan variation when compared 
to control. Taken together, our results demonstrate a fully 
functional Insulin/Igf-like/PI3-kinase signalling pathway 
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class-mutants is believed to occur by de-repression of 
the FOXO transcription factor family member DAF-16 
[41].  Daf-16 gene products are thought to be 
permanently under negative regulation by the daf-2/age-
1 genetic pathway. Therefore, strong daf-16 loss-of-
function alleles can suppress the long-lived phenotype 
of  daf-2 mutants. We thus submitted the daf-16 
(mgDf50) deletion mutant to klotho RNAi. As expected, 
worm lifespan was not affected (LogRank p = 0.996) in 
this genetic background (Figure 4E; Table 2). This 
result makes the daf-16 gene a major output for klotho 
gene effect on worm lifespan modulation.  
 
In summary our data demonstrate that Klotho can 
significantly convert an N2 (wild type) worm lifespan 
(Figure 4A; Table 2) to a shorter one. However, since 
this negative lifespan modulation vanished when daf-2, 
age-1 or daf-16 mutants were submitted to klotho 
knockdown, we propose that Klotho de-represses DAF-
16 by constitutively down-regulating DAF-2. Therefore 
we provide here strong evidence for a direct link 
between the Insulin/Igf-like/PI3-kinase/FOXO signal-
































lation in a whole organism, which then argues for an 
evolutionary conserved mechanism. 
 
5- Klotho requires functional EGL-17/EGL-15 
signalling to improve oxidative stress resistance in a 
DAF-16-dependent and DAF-2-independent 
mechanisms  
 
It has been reported that Klotho can increase oxidative 
stress resistance at the cellular and organism levels in 
mammals [42, 43]. It is also believed that FOXO 
transcription factor de-repression by Klotho-induced 
downregulation of Insulin/Igf-like signalling should 
induce antioxidant enzymes overexpression.  
 
Two antioxidant enzymes: manganese superoxide 
dismutase and catalase are known to facilitate removal 
of reactive oxygen species towards a permanent 
molecular scavenger action. Since increased resistance 
to oxidative stress has been associated with increased 
longevity in various species, including C. elegans [44], 
we then asked if Klotho may help protecting worms 
when subjected to a sub-lethal oxidative stress induced 
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of-function allele and the daf-16 (mgDf50) deletion 
mutant, fed with either control or klotho RNAi, 
displayed an increased sensitivity to oxidative stress in 
similar fashion to the N2 (wild-type) worms fed with 
klotho RNAi only. As expected, similar results were 
obtained when the egl-17(n1377) reduction-of-function 
allele was used in place of the egl-15(n484) mutant (not 
shown).  
 
These data suggest that Klotho requires functional 
EGL-17/EGL-15 signalling to improve oxidative stress 
resistance in a DAF-16-dependent manner. We further 
checked whether Klotho requires a fully functional 
DAF-2 tyrosine kinase domain to improve oxidative 
stress resistance. Surprisingly, the daf-2(e1370) loss-of-
function allele showed an increased susceptibility to 
oxidation when fed with klotho RNAi with respect to 
control RNAi. Since the functional activity of the 
tyrosine kinase domain is impaired in this class mutant 
allele, our results strongly suggest that Klotho may 
activate DAF-16 by a different pathway from the 
canonical worm DAF-2/DAF-16 signalling cascade. 
Interestingly, some reports using mammalian models 
have shown possible FOXO activation by alternative 
pathways that involve inhibition of the serum- and 
glucocorticoid-inducible kinase SGK [46] or activation 





Here, we report the first investigation of klotho gene 
function in a non-mammalian organism. The choice of 
the nematode C. elegans was motivated by the 
evolutionary conservation, from worm to human, of the 
signalling pathways controlling both longevity and 
oxidative stress resistance. The functional activity of 
Klotho in worms was investigated using a genetic 
approach, based on the simultaneous knockdown of 
both worm klotho paralogues, coupled to an epistatic 
analysis in relevant genetic backgrounds.  
 
We first looked for a potential interaction between 
Klotho and FGF signalling, in C. elegans. Our results 
demonstrate that Klotho requires EGL-15, the single 
FGFR identified in worms, to regulate both lifespan and 
oxidative stress resistance. This suggests, at least in C. 
elegans, that the predicted KL1 isoform of Klotho may 
interact with the FGF pathway, possibly by targeting 
FGFR. Interestingly, N-glycosylation has been recently 
reported to negatively regulate EGL-15 activity in vivo 
[49]. According to our data, such a finding leads to the 
hypothesis that Klotho, via its putative sialidase 
activity, could de-repress EGL-15 by favouring the 
removal of inhibitory N-glycans. 
Then, to assess the possible involvement of a specific 
EGL-15 ligand in Klotho signalling, three lines of 
evidence allowed us to discriminate between LET-756 
and EGL-17: (i) the egl-15 (n484) reduction-of-function 
allele used here has been reported to mimic the 
phenotype of an egl-17 reduction-of-function allele 
[35]; (ii) similar results were obtained using the egl-17 
(n1377) reduction-of-function allele in place of egl-15 
(n484); (iii) Klotho did not interfere with fluid balance 
regulation controlled by LET-756.  
 
Taken together, our data demonstrate that the EGL-17 
ligand is necessary and sufficient for Klotho signalling 
expression. Since the EGL-15(5A) isoform is 
specifically recognized by EGL-17 [26, 27], a 
Klotho/EGL-17/EGL-15(5A) complex may positively 
regulate lifespan and oxidative stress resistance in 
worms.  
 
Both phylogenetic and functional studies suggest that 
EGL-17 could be included, like mammalian FGF8, -17 
and -18, in the FGF8 subfamily [50]. Interestingly, 
FGF8 may protect mammalian cultured neurones from 
oxidative stress [51]. Moreover, while a decrease in 
FGF8 signalling has been related to hypogonadotropic 
hypogonadism in human and mice [52], a similar 
syndrome was characterized in Klotho-deficient mice 
[11]. In C. elegans, EGL-17 is localized in the gonad 
where it functions as a chemo-attractant for the EGL-
15(5A)-expressing SMs, during larval development [25, 
50]. By the new involvement of a possible Klotho/EGL-
17/EGL-15(5A) complex in the control of both 
longevity and stress resistance, our results help to 
unravel a new post-developmental role for EGL-17 in 
C. elegans.  
 
The secreted Klotho is already known to inhibit both 
insulin and IGF1-induced receptor autophosphorylation, 
when applied to cultured mammalian cells [2, 53]. In 
accordance with these data, we report that Klotho 
requires a functional DAF-2 Insulin/Igf-like/Daf-16 
(FOXO) pathway for positive modulation of worm 
lifespan.  
 
We also demonstrate in a whole organism that Klotho 
may physiologically repress the tyrosine kinase activity 
of DAF-2 activated in either a ligand-dependent or -
independent manner. Although the mammalian secreted 
Klotho is believed to behave independently of FGF 
signalling, the predictive KL1 isoform of Klotho 
requires EGL-17/EGL-15(5A) to regulate longevity in 
worm. Interestingly, a signal produced by the somatic 
gonad has been reported to lengthen worm lifespan by 
inhibiting DAF-2 (Insulin/Igf-like) activity [54]. Since 
the nature of this signal is still unknown, it is tempting 
to speculate that the putative Klotho/EGL-17/EGL-
   
www.impactaging.com                   576                                  AGING, September 2010, Vol.2 No.915(5A) complex, that is primarily localized in the 
gonad, could take part in the molecular mechanism of 
this yet unknown signalling. 
 
The secreted Klotho has also been reported to suppress 
oxidative stress in mammals [42, 43]. Indeed, the de-
repression of FOXO consecutive to the inhibition of the 
Insulin/Igf-like signalling up-regulates the expression of 
antioxidant enzymes that are known to facilitate the 
removal of reactive oxygen species. Here, we report that 
Klotho, together with EGL-17/EGL-15(5A), improves 
worm oxidative stress resistance towards a DAF-16-
dependent manner. In addition, by the use of a daf-2 
(e1370) loss-of-function allele, we report that the 
protective effects of Klotho against a potent oxidative 
stress are independent of a functional DAF-2 receptor. 
The fact that C50F7.10 was found to be overexpressed 
in daf-2 mutants [55] also supports this finding.  
 
Our results strongly suggest that Klotho may activate 
DAF-16 by a pathway that is different from the 


































Interestingly, several studies have shown that FOXO 
can be activated by alternative pathways, involving the 
inhibition of the serum- and glucocorticoid-inducible 
kinase SGK [46] or the activation of, either the c-Jun 
NH2-terminal kinase (JNK) [47] or β-catenin [48]. 
 
In summary, our data suggest that Klotho could target 
either worm DAF-2 or DAF-16, depending of environ-
mental cues. Indeed, Klotho seems to constitutively 
repress DAF-2 throughout lifespan while it could also 
directly activate DAF-16 when the nematode has to 
cope with intense stress (Figure 6). Since a functional 
EGL-17/EGL-15(5A) signalling is required in all cases, 
the predicted KL1 form of Klotho appears to link FGF 
and Insulin/Igf-like pathways, in C. elegans. How these 
two pathways can crosstalk remains to be determined. A 
potential intermediate could be the adaptor protein 
SHC-1, homologue of human p52Shc, that has been 
recently reported to modulate lifespan and stress 
response in C. elegans. Indeed, SHC-1 was shown to 
repress DAF-2 by an unknown mechanism and to 
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Strains and culture conditions.  The following strains 
were used: Wild type Bristol (N2); E02H9.5 (ok1830); 
MT1079  egl-15(n484); MT3188 egl-17(n1377); 
CB3241  clr-1(e1745); PJ1153 clr-1(e1745) [let-
756(s2613) unc-32(e189) ccls55]; CB1370 daf-
2(e1370); GR1032 age-1(mg44)/mnC1  [dpy-10(e128) 
unc-52(e444)]; GR1307 daf-16(mgDf50) which were all 
provided by the Caenorhabditis Genetics Center 
(funded by the NIH National Center for Research 
Resources). DR1567 daf-2(m577) was kindly provided 
by David Gems, University College London, UK. 
Worms were maintained at 15°C and, unless specified, 
cultured at 20°C as described previously [57]. 
 
Expression of RNAi constructs. E02H9.5 and C50F7.10 
entire ORFs were cloned from C. elegans cDNA into a 
pBluescript II KS (+/-) vector (Stratagene, La Jolla, CA, 
USA). RNAi constructs were obtained after E02H9.5 
and C50F7.10 ORFs were amplified from pBluescript II 
KS (+/-) and 1425 and 1464 bp respective fragments 
were inserted at the SmaI site of a pPD129.36 (L4440) 
vector (a generous gift of Johnathan Ewbank, CNRS, 
Marseille, France). RNAi producing bacteria were 
obtained as follows: after transformation with either 
pPD129.36, E02H9.5 or C50F7.10 RNAi construct, 
HT115 (DE3) strain bacteria were grown in LB medium 
in presence of both Ampicillin (50 μg/ml) and 
Tetracyclin (12,5 μg/ml) during 8 h, then seeded on 
NGM plates containing FUdR (98,5 μg/ml), Ampicillin 
(50 μg/ml) and IPTG (1mM) and induced overnight. 
 
RNAi feeding and lifespan assays.  Synchronized L4 
larvae fed with RNAi producing bacteria were allowed 
to grow at 20°C until death on supplemented NGM 
plates, including FUdr to avoid offspring [58]. Worms 
were examined every day for touch-provoked 
movement, dead worms were scored and worms that 
crawled off the plate or displayed extruded internal 
organs were censored. All lifespan assays were repeated 
at least three times. XLSTAT-life statistical software 
(Addinsoft, New York, NY, USA) was used to plot 
survival data by the Kaplan-Meier method and 
differences between survival curves were calculated 
using the LogRank test with 95% confidence. 
 
Real-time PCR. Synchronized N2 adult worms were fed 
with RNAi producing bacteria during 4 days at 20°C, 
total RNA was isolated and cDNAs were synthesized as 
previously described [45]. Real-time PCRs were 
performed in capillaries, using LightCycler Fast Start 
DNA Master
plus Sybr Green I kit  (Roche Diagnostics, 
Meylan, France). Primers for the reference gene TBA2 
are: Forward primer: 5’-CCTCCTCCGAATGAATGA 
AA-3’; Reverse primer:  5’-TCCGATACTGGAAACG 
GAAG-3’. Primers for E02H9.5 are: Forward primer: 
5’-ATAGGCAATATTTTGTTAGT-3’; Reverse primer: 
5’-GCTGAAGCCGCGGCCATTCA-3’. Primers for 
C50F7.10 are: Forward primer : 5’-GATATTCTGACC 
TCTTACAG-3’; Reverse primer : :  5’-ATCCCAAGT 
ACTGAATCCGC -3’. To avoid cross-amplification of 
RNA sequence present in RNAi-fed worms, both 
E02H9.5 and C50F7.10 specific forward primers were 
designed to hybridize the 5’-UTR region not included in 
the RNAi-targeted sequences. The corresponding 
reverse primers were designed to hybridize the 
boundary of the first and the second exons in order to 
prevent cross-amplification of possible contaminating 
genomic DNA. The RNA level of each gene of interest 
was normalized to the tba-2 reference gene level for 
comparison and results of three independent 
experiments were treated as described in (Pfaffl, 2001). 
As shown in Figure S1, each construct was able to 
induce a similar knockdown of both C50F7.10 and 
E02H9.5 gene expression. Thus, in this study, the 
knockdown of both paralogues, indifferently induced by 
either construct, will be referred as klotho RNAi and the 
product of either C. elegans gene will be named Klotho. 
 
Clr phenotype suppression assay.  Clr-1-suppressing 
activity was assayed in a temperature-sensitive clr-
1(e1745) background. After 4 days of RNAi treatment at 
15°C, adult worms were either maintained at the 
permissive temperature (15°C) or shifted to the restrictive 
temperature (25°C), then examined 24h later for the 
suppression of the Clr phenotype. At least 50 worms 
were examined per plate and results are representative of 
three independent experiments. Worms were 
photographed under bright-field illumination.  
 
Oxidative stress resistance assays. Menadione was used 
as a potent oxidative stress inducer, as previously 
described [45]. After 4 days of RNAi treatment at 20°C, 
adult worms from different genetic backgrounds were 
transferred onto 24-well plates (about 30 worms per 
well) containing S complete medium supplemented with 
25 mM of Menadione (Sigma-Aldrich) and transformed 
HT115 bacteria to maintain the RNAi treatment during 
the assay. Controls were performed in the absence of 
Menadione. At least four independent experiments were 
carried out for 72h at 20°C and the viability of worms 
was scored, using 1 μM SYTOX Green Nucleic Acid 
Stain (Molecular probes) to discriminate fluorescent dead 
worms. Survival histograms were analyzed with 
XLSTAT software (Addinsoft, New York, NY, USA), 
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Figure  S1.  Targeting  for  klotho gene  expression  by  RNAi.  N2  adult  worms  were
submitted to RNAi feeding for either C50F7.10 or E02H9.5 gene knockdown. The relative mRNA
levels  for  each  gene  were  quantified  using  LightCycler  software  (Roche  Diagnostics).  After
normalization to the mRNA level of tubulin (TBA2), results were treated as described in [59] and
expressed as mean + standard error of the mean (SEM) from three independent experiments. 